000 | 01481 a2200421 4500 | ||
---|---|---|---|
005 | 20250517031630.0 | ||
264 | 0 | _c20160509 | |
008 | 201605s 0 0 eng d | ||
022 | _a1365-2141 | ||
024 | 7 |
_a10.1111/bjh.13480 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUgocsai, Peter | |
245 | 0 | 0 |
_aBiomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma. _h[electronic resource] |
260 |
_bBritish journal of haematology _cJan 2016 |
||
300 |
_a290-3 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBrentuximab Vedotin |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoconjugates _xadministration & dosage |
650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aSalvage Therapy _xmethods |
700 | 1 | _aWolff, Daniel | |
700 | 1 | _aMenhart, Karin | |
700 | 1 | _aHellwig, Dirk | |
700 | 1 | _aHoller, Ernst | |
700 | 1 | _aHerr, Wolfgang | |
700 | 1 | _aReichle, Albrecht | |
773 | 0 |
_tBritish journal of haematology _gvol. 172 _gno. 2 _gp. 290-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjh.13480 _zAvailable from publisher's website |
999 |
_c24871848 _d24871848 |